Benzyl butyl phthalate induces migration, invasion, and angiogenesis of Huh7 hepatocellular carcinoma cells through nongenomic AhR/G-protein signaling
- Cheng-Fang Tsai1,
- Tsung-Hua Hsieh1,
- Jau-Nan Lee2,
- Chia-Yi Hsu1,
- Yu-Chih Wang2,
- Feng-Jie Lai3,
- Kung-Kai Kuo4,
- Hua-Lin Wu5, 6, 7,
- Eing-Mei Tsai†1, 2, 8Email author and
- Po-Lin Kuo†9Email author
© Tsai et al.; licensee BioMed Central Ltd. 2014
Received: 28 October 2013
Accepted: 18 July 2014
Published: 1 August 2014
The widespread use of phthalates as plasticizers has raised public health concerns regarding their adverse effects, including an association with cancer. Although animal investigations have suggested an association between phthalate exposure and hepatocellular carcinoma, the mechanisms are unknown.
The hepatocellular carcinoma cell line Huh7 was treated with benzyl butyl phthalate (BBP), and then analyzed by total internal reflection fluorescence microscopy, confocal microscopy and double immunogold transmission electron microscopy. Following BBP treatment, mRNA levels were measured by RT-PCR, protein levels were measured using western blot, and vascular endothelial growth factor levels were measured by an enzyme-linked immunosorbent assay. Cell migration and invasion assays were evaluated by transwell, and angiogenesis were performed by a tube formation assay. Nude mice were used to investigate metastasis and angiogenesis in vivo.
BBP affected hepatocellular carcinoma progression through the aryl hydrocarbon receptor (AhR) and that benzyl butyl phthalate (BBP) stimulated AhR at the cell surface, which then interacted with G proteins and triggered a downstream signaling cascade. BBP activated AhR through a nongenomic action involving G-protein signaling rather than the classical genomic AhR action. BBP treatment promoted cell migration and invasion in vitro and metastasis in vivo via the AhR/Gβ/PI3K/Akt/NF-κB pathway. In addition, BBP induced both in vitro and in vivo angiogenesis through the AhR/ERK/VEGF pathway.
These findings suggest a novel nongenomic AhR mechanism involving G-protein signaling induced by phthalates, which contributes to tumor progression of hepatocellular carcinoma.
KeywordsPhthalate Aryl hydrocarbon receptor Angiogenesis Migration Hepatocellular carcinoma
Globally, hepatocellular carcinoma is the sixth most common cancer and the third most common cause of cancer-related deaths . Risk factors for hepatocellular carcinoma include infection with hepatitis B or C viruses, alcohol consumption, smoking, and environmental factors . Oral administration of phthalates to rats results in liver enlargement and cause increased malondialdehyde levels in the liver, indicating that phthalates cause oxidative damage of the liver . Bis(2-ethylhexyl) phthalate (DEHP) acts as a promoter of hepatocellular tumors initiated by N-nitrosodiethylamine . Moreover, lifetime DEHP treatment induces testis and liver cancer in rats . Based on proteomic analysis, the proteins secreted by HepG2 cells that have been treated with benzyl butyl phthalate (BBP) are associated with DNA damage, tumor progression, apoptosis, energy metabolism, and cell structure and motility . The observed roles of BBP in DNA damage and methylation, as well as cell migration, invasion, and proliferation suggest the involvement of BBP in tumor development and progression. These findings support carcinogenesis induced by phthalates, but the mechanism remains largely unknown.
Previous studies have shown that phthalates affect the activation of the aryl hydrocarbon receptor (AhR) [7, 8]. Moreover, phthalates suppressed type I interferon expression in human plasmacytoid dendritic cells via AhR . Our previous study showed that BBP induces necrosis in human granulosa cells via AhR activation followed by downstream CYP1B1 induction . We also showed that phthalates induce proliferation and invasiveness of breast cancer through the AhR/HDAC6/c-Myc signaling pathway . These results suggest that AhR is an important receptor that mediates multiple biological effects of phthalates.
The ligand-activated transcriptional factor AhR regulates the enzymatic functions needed for xenobiotic metabolism. Previous reports revealed two pathways that mediate AhR effects including genomic and non-genomic pathways. The classical genomic function involves AhR nuclear translocation and binding to xenobiotic responsive elements located in the promoters of target genes, CYP1A1 and CYP1B1 . In addition to the classical genomic AhR function, AhR can regulate gene expression through a nongenomic mechanism. The Study of nongenomic signaling is important in the field of toxicology. It is difficult to identify dioxin response element (DRE)-based target genes and many reports suggest that the toxic effect of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) is more compatible with the nongenomic signaling of AhR, rather than the genomic action . Moreover, our previous study reported a phthalate mediated AhR/HDAC6/c-Myc pathway that demonstrated a nongenomic effect of AhR . Several studies have reported that TCDD induces inflammatory responses through a nongenomic AhR function [14–17], although this nongenomic AhR function remains poorly understood.
Here, we found that BBP promotes angiogenesis, migration and invasion in vitro as well as angiogenesis and metastasis in vivo of hepatocellular carcinoma. Because G-protein signaling is involved in the regulation of AhR stability , we further investigated the AhR function and its possible relationship to G-protein signaling in hepatocellular carcinoma.
Additionally, we revealed that the mechanism through which phthalates activate the nongenomic AhR pathway is associated with G-protein signaling.
Chemicals and plasmid
Fluo-4 was purchased from Invitrogen (Carlsbad, CA, USA). BBP, 2-aminoethoxydiphenyl borate (2-APB), and 6-diamidino-2-phenylindole (DAPI) were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA). Pd98059 and wortmannin were obtained from Calbiochem-Novabiochem (San Diego, CA, USA).
pEGFP-C1-AhR, a kind gift from Dr. Hsin-yu Lee (Department of Life Science, National Taiwan University), was cloned the AhR gene into pEGFP-C1 (Clontech).
Huh7 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Life Technologies, Grand Island, NY, USA), PLC/PRF/5 and HepG2 cells were cultured in minimum essential medium (MEM) (Life Technologies, Grand Island, NY, USA) and supplemented with 10% fetal bovine serum (Gibco, California,CA, USA), 1% penicillin (100 U/mL), streptomycin (10 μg/mL), and amphotericin-B (250 μg/mL) (Sigma-Aldrich Co, St. Louis, MO). Human umbilical vein endothelial cells (HUVEC) were grown in EGM-2 medium (Lonza, Basel, Switzerland). All cells were cultured at 37°C in 5% CO2.
Total internal reflection fluorescennce microscopy
For total internal reflection fluorescennce (TIRF) microscopy studies, Huh7 cells were transfected with pEGFP-C1-AhR or pEGFP-C1 as a control using LT1 transfection reagent (Mirus, Madison, WI, USA). After transfection for 24 hours, the cells were harvested and cultured on coverslips for 1 day. Cells were then treated with DMSO as a control or BBP (1 μM) and analyzed by TIRF microscopy (Carl Zeiss, Oberkochen, Germany). GFP intensity was analyzed by Axio Vision Rel. 4.8 software (Carl Zeiss, Oberkochen, Germany).
Calcium imaging was performed using the same method as in a previous study  with some modifications. For live cell calcium imaging, Cell-R software was used for microscopy (Olympus, Japan). Huh7 cells were seeded on coverslips and cultured for 24 hours. Cells were incubated with 1 μM Fluo-4, a Ca2+-specific dye, at 37°C for 20 minutes in Buffer Salt Saline (BSS) (2 mM CaCl2, 5.5 mM d-glucose, 130 mM NaCl, 5.4 mM KCl, 20 mM HEPES pH = 7.4, 1 mM MgSO4) and then washed three times before measuring the relative fluorescence intensity. Cells were pretreated with various concentrations of 2-APB for 10 minutes, and then loaded with 1 μM Fluo-4 for 20 minutes. After washing, cells were maintained in calcium-free medium (5.5 mM d-glucose, 130 mM NaCl, 5.4 mM KCl, 20 mM HEPES (pH = 7.4), and 3 mM MgSO4) during the experimental periods. The cells were then stimulated by adding BBP (1 μM) after 1 minute. Data were analyzed with Cell-R software.
Huh7 cells were transfected with pEGFP-C1-AhR using LT1 transfection reagent. After overnight transfection, the cells were harvested and cultured on coverslips for 1 day. BBP (1 μM) was added to stimulate the cells before analysis by confocal microscopy. GFP intensity was analyzed by FV10-ASW 3.0 software (Olympus, Japan).
Double immunogold transmission electron microscopy
Ultrathin sections of plastic-embedded cells were pretreated with 5% sodium metaperiodate (10 min) by microwave fixation and processing. The grids were incubated with an aliquot of IgG antibodies against AhR or Gαq/11 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) followed by probing with secondary antimouse IgG gold particles (6 nm) or anti rabbit IgG gold particles (20 nm), respectively. After washing, the sections were blocked by placing the grids on a drop of phosphate-buffered saline (PBS) containing 1% ovalbumin and incubating for 15 minutes. Sections were then stained with uranyl acetate and lead citrate for characterization by transmission electron microscopy (H-700, Hitachi, Japan).
Fluorescence in situ hybridization
After treatment with BBP (1 μM) or DMSO for the control group, cells were fixed by adding fixation solution (in 3.7% formaldehyde/PBS) at room temperature for 10 minutes. The cells were washed with PBS twice and then permeabilized by adding 70% EtOH at 4°C for 1 hour. Cells were then washed in wash buffer (5 mL 20× saline-sodium citrate (SSC), 5 mL formamide, and nuclease-free water to a final volume of 50 mL) for 5 minutes. Hybridization was performed by mixing 100 μL of hybridization solution (1 g dextran sulfate, 20 × SSC, 1 mL formamide for a 10% final concentration and nuclease-free water to a final volume of 10 mL) with a specific AhR probe (Stellaris™ FISH Probes, Biosearch Technology, Novato, CA, USA) and incubating the mixture overnight at 37°C. Cells were then stained with DAPI (1 μg/mL) for 5 minutes. After washing, a drop of mounting solution was applied. The slides were then covered with the cell-attached cover glasses and sealed with nail polish. Imaging was performed by confocal microscopy.
RNA isolation and RT-PCR
Huh7 cells (3 × 105) were seeded in six-well plates, cultured for 24 hours, and then incubated overnight in serum free medium. The cells were then treated with BBP (1 μM) for various times intervals. After stimulation, cells were washed twice with PBS. Total RNA was extracted with TRIzol (Invitrogen). The RNA (2 μg) was applied to a Reverse Transcription System (Promega Biosciences, San Luis Obispo, CA, USA) to synthesize cDNA. The cDNA was then amplified by specific primers. The primer pairs were as follows: AhR, forward 5′-TACTCTGCCGCCCAA ACTGG-3′, reverse 5′-GCTCTGCAACCTCCGATTCC-3′; β-actin, forward 5′-CTCGCTGTCCACCTTCCA-3′, reverse 5′-GCTGTCACCTTCACCGTTC-3′. The PCR conditions were 95°C for 5 min, and then 34 cycles of 95°C for 30 sec, 54°C for 30 sec, and 72°C for 1 min, and a final extension at 72°C for 10 min. PCR products were separated on 2% agarose gels and visualized using ethidium bromide.
siRNA and shRNA transfection
The following siRNAs were used: scrambled siRNA sense: 5′-GAUCAUACGUGCGAUCAGA-3′, antisense: 5′-UCUGAUCGCACGUAUGAUC-3′ ; AhR siRNA (SASI_Hs02_00332181, Sigma). The following shRNAs were obtained from the National RNAi Core Facility at Academic Sinica: control shRNA, 5′-TACAACAGCCACAACGTCTAT-3′; AhR shRNA (1) (TRCN0000021255), AhR shRNA (2) (TRCN00000245285), NF-κB shRNA (1) (TRCN0000006518), and NF-κB shRNA (2) (TRCN0000006520). Cells were transfected with siRNA (10 nM) or shRNA (2 μg) using LT1 transfection reagent.
Whole cell extracts were prepared in RIPA lysis buffer (Millipore, Temecula, CA, USA) containing 1× protease inhibitor cocktail (Thermo Scientific, Waltham, MA, USA). Protein concentrations were determined using a BCA protein assay kit (Thermo Scientific, Rockford, IL, USA). Equal amounts of protein (50 μg protein) were resolved by sodium dodecyl sulfate-polyacaryamide gel electrophoresis (SDS-PAGE), transferred onto a polyvinylidene difluoride membrane, and blocked with 5% nonfat dry milk for 1 hour at room temperature. After blocking, the membrane was incubated overnight with primary antibodies at 4°C and washed three times with PBST. The horseradish peroxidase conjugated secondary antibodies (Santa Cruz Biotechnology) were incubated for 1 hour at room temperature. The blots were washed three times with PBST and then visualized with an enhanced chemiluminescence kit (Thermo Scientific, Rockford, IL, USA). The primary antibodies were as follows: AhR, Gαq/11, Gβ, PIP2, IP3R, and PI3K from Santa Cruz Biotechnology (1:100); p44/42 MAPK (Erk1/2), Akt, p-Akt (ser473), NFκB, LaminA/C, Histion H3 and α-tubulin from Cell Signaling Technology (1:1000); COX-2 from Abcam (1:1000); β-actin from Sigma (1:1000).
After preclearing for 30 minutes with protein G agarose (Millipore), antibodies specific for Gαq/11, Gβ, or PI3K (1:100; Santa Cruz Biotechnology) or IgG (2 μg, Sigma-Aldrich Co, St. Louis, MO, USA) were added before overnight incubation at 4°C, followed by precipitation for 2 hours with protein G agarose. The beads were washed three times with RIPA lysis buffer, boiled in sample buffer, and the protein were resolved by 8% SDS-PAGE before performing immunoblot analysis of the indicated proteins.
Transwell migration and invasion assays
Cell migration assays were performed in 24-well inserts (8-μm pore size; BD Biosciences, Franklin Lakes, NJ, USA) and cell invasion assays were performed in 24-well Matrigel™ Invasion inserts (8-μm pore size; BD Biosciences, Franklin Lakes, NJ, USA). Cells (1 × 104) in serum-free DMEM were seeded in the upper chamber of the insert and DMEM containing 10% fetal bovine serum was added to the lower chamber and followed by incubation for 1 day (for migration) or 2 days (for invasion). The medium and cells were then removed from the top chamber using cotton swabs and PBS. The cells were fixed with 4% paraformaldehyde for 30 minutes, stained with a 0.5% crystal violet solution for 2 hours, and counted under a microscopy.
Measurement of vascular endothelial growth factor
Huh7 cells were grown in 12-well plates and treated with BBP for 1 day. After treatment, the cells were incubated in fresh medium for 1 day. The media were then collected and centrifuged at 1,000 rpm for 5 minutes to remove cell debris. Vascular endothelial growth factor (VEGF) levels in the conditioned medium were measured with an enzymed-linked immunosorbent assay (ELISA) kit (R&D System, Minneapolis, MN, USA).
Angiogenesis tube formation assay
HUVEC (2 × 104 cells/mL) were seeded in a 48-well plate pre-coated with Matrigel (BD Biosciences, San Jose, CA, USA). After Huh7 cell-conditioned medium was added to a final volume of 20%, the cells were cultured for 16 hours, stained with calcium-AM (Invitrogen), and visualized under a fluorescence microscope (Olympus). Total tube lengths were measured by MetaMorph software (Leica)
Male 6-week-old nude mice (BALB/cA-nu nu/nu) were purchased from the National Science Council Animal Center (Taiwan). All animal experiments were performed according to a protocol approved by the Institutional Animal Care and Use Committee of Kaohsiung Medical University Hospital (IACUC Approval No: 101060).
In vivotumor xenograft experiments
Huh7 cells were stably transfected with infrared fluorescent protein . Briefly, 293 T cells were transfected with pCMV-ΔR8.91, pMD.G, and pLKO AS3-reporter gene using LT1 transfection reagent for 3 days, and the supernatant (lentivirus-containing medium) was collected the next day. Huh7 cells (2 × 105) were seeded into six-well plates and incubated for 1 day. The lentivirus-containing medium (200 μL) was mixed with 800 μL of DMEM containing 8 μg/mL polybrene and added to each well, and the cells were incubated for 1 day. A stable clone was selected by puromycin treatment (2 μg/mL) for 14 days. The cells were incubated with 25 μM biliverdin overnight and then purified Huh7-IFP cells by flow cytometry. The hepatocellular carcinoma model of direct intrahepatic injection was performed according to a previous study  with some modifications. After a small incision was made in nude mice to access the liver, Huh7-IFP cells (1 × 106) suspended in PBS were slowly injected into the upper left lobe of the liver using a 28-gauge needle. A transparent bleb of cells was formed through the liver capsule after injection. To prevent bleeding, a small piece of sterile gauze was placed, and light pressure was applied on the injection site. After implantation, the mice were placed on a heating pad or below a heating lamp until fully active. The mice were randomly divided into two groups (vehicle or BBP treatment), 18 mice of each. After 3 days, BBP (500 mg/kg) was administered by intraperitoneal (i.p.) injection every 2 days. Previous studies have reported that administration of BBP by i.p. at a dose of 800 mg/kg for 24 weeks results in no significant toxic effects [11, 22], which is a higher dose than that used in this study. Tumor growth was detected by injecting biliverdin (250 nM) into the tail vein 30 minutes before imaging. After 1 month, the mice were sacrificed and the organs (liver, lungs, kidneys, and spleen) were removed and viewed with an Ultra Sensitive Molecular Imaging System (Berthold Technology). The numbers of the organs (lung, kidneys, spleen) that expressed fluorescence, considered as metastasis positive organs were determined.
Liver tissues were fixed with 4% paraformaldehyde, embedded in paraffin, and cut into 4-μm thick sections. The sections were deparaffinized in xylene and rehydrated with a graded series of ethanol/water solutions (100% and 95% ethanol) and then water washes. The sections were treated with 10 mM citrate buffer at 95°C to retrieve antigens and blocked with 5% bovine serum albumin. Primary antibodies against PI3K (1:100; Santa Cruz Biotechnology) and NF-κB (1:200; Cell Signaling) were applied to the sections at 4°C overnight, and then the sections were incubated with secondary antibodies and 3,3’-diaminobenzidine. Intensities of PI3K and NF-κB staining were analyzed by Tissue Quest software (Tissue Genomics)
In vivo Matrigel™ -plug angiogenesis assay
Huh7 cells (3 × 106) were suspended in 150 μL PBS, mixed with 50 μL Matrigel (BD Biosciences), and injected into the flanks of nude mice. BBP (1 μM) was added to the cell suspensions of the treatment groups. After 21 days, the Matrigel plugs were removed. Hemoglobin levels were determined by Drabkin reagent (Sigma), and protein concentrations were normalized to measure blood vessel formation.
Statistical significance was established using the Student’s t-test. A p-value of < 0.05 was considered statistically significant.
BBP induced AhR expression
BBP activates AhR at the cell membrane, which interacts with G proteins
Initial activation of COX-2 by AhR/Gαq/11signaling
Effect of BBP on cell migration and invasion through AhR/Gβ/PI3K/Akt/NF-κB signaling
BBP promotes in vivometastasis
The mouse intrahepatic injection model was established to examine tumor metastasis . Huh7-IFP cells (1 × 106) were suspended in 30 μL PBS and injected into the mouse liver (At 3 days after of implantation, 500 mg/kg BBP was administered by i.p. injection every 2 days. Weekly imaging of the mice confirmed that the tumor sizes increased over time (Figure 5C). The mice were sacrificed after 1 month to compare tumor metastasis between control and BBP treatment groups. The metastasis rates in the lungs, kidneys, and spleen were higher in the BBP treatment group than those in the control group (Figure 5D), suggesting that BBP promotes metastasis. Immunohistochemistry showed that liver PI3K and NF-κB levels were significantly higher in the treatment group than those in the control group (Figure 5E).
BBP promotes angiogenesis in vitro and in vivo
In this study, we provide evidence that phthalate promotes hepatocellular carcinoma progression through a nongenomic AhR pathway. Rodent studies of the carcinogenesis of phthalate have yielded substantial data . Some human epidemiological studies have also shown a cancer risk associated with phthalate exposure, including respiratory cancer , pancreatic cancer , and breast cancer . However, the mechanisms of carcinogenesis have been rarely explored for phthalate. To further investigate such mechanisms, we treated hepatocellular carcinoma cell lines, Huh7, HepG2 and PLC cells with BBP (1 μM). All cell lines showed the activation of AhR after treatment (Additional file 1: Figure S1). We then tested the functions of cells treated with BBP including migration, invasion and angiogenesis. We found that BBP induced migration of Huh7 and PLC cell lines. In addition, BBP induced invasion and angiogenesis of Huh7 cells (Additional file 2: Figure S2). These results may be due to the higher constitutional level of AhR in Huh7 than in that in PLC cells (Additional file 2: Figure S2D). HepG2 cells are not appropriate for further animal studies for non-tumorigenic properties in immunosuppressed mice . Therefore, we further investigated the mechanism induced by BBP in Huh7 cells. We used Huh7 cells in the in vivo study, and clarified the effect of BBP induced metastasis and angiogenesis in vivo.
Our current study showed that BBP treatment induces a nongenomic function through AhR and further clarified that AhR translocates to the membrane and subsequently activates G-protein signaling. Our investigation is consistent with a previous report in the nongenomic AhR mechanism induced by TCDD, showing that TCDD rapidly increases calcium concentrations and induces COX-2 expression in U937 macrophages, mouse MMDD1 macula densa cells, and MCF10 cells [14, 17]. We believe that the nongenomic action explains why cells elict fast inflammatory responses to the environmental pollutant TCDD and the endocrine disrupting agent, phthalate. After BBP treatment, the AhR mRNA levels were unregulated. Certain molecular such as NF-κB, interleukin (IL)-27 and IL-6 were investigated that can regulate AhR expression [32–34]. However, the mechanism of BBP induced AhR mRNA upregulation has remained unclear. Subsequently the nongenomic action triggers the cell signal pathways and affects the cell function. A previous study showed that by interacting with AhR-interacting protein, Gα13 destabilized AhR via the ubiquitin-proteasome pathway . Polycyclic aromatic hydrocarbons (PAH), which is the AhR ligand, induceds expression of AhR target genes through directed bind to G protein coupled receptor and activates G protein/ cAMP/ 1,4,5-trisphosphate (IP3) pathway, which results in calcium induction . The current study further confirmed that AhR positively regulates G proteins, including Gαq/11 and Gβ through nongenomic mechnissams. To our knowledge, the present study is the first investigation to elicit that phthalate activates AhR through a non-genomic mechanism that involving G protein signaling. Importantly, we provide evidence that the tumor progression, including migration, invasion and angiogenesis were regulated by this phthalate-induced signaling pathways.
Immortalized fibroblasts from Ahr −/− mice demonstrate a lower tumorigenic potential because of diminished cell motility and responses to angiogenic factors . Overexpression of AhR promotes the development of malignant cellular phenotypes and also increases their cell proliferation rate, motility, migration, and confers the ability to invade Matrigel in immortalized normal human mammary epithelial cells . Activation of AhR is functionally connected to a signaling cascade that dramatically alters plasticity and increases motility in MCF-7 cells .
Angiogenesis contributes to tumor metastasis . It has been reported AhR regulates both in vitro and in vivo angiogenesis. AhR−/− endothelial cells fail to form tube-like structures, and impaired angiogenesis limits tumor xenograft growth in AhR null mice . The current study showed that BBP promoted angiogenesis through nongenomic AhR mechanisms, and VEGF expression was increased by ERK1/2 phosphorylation. This finding is consistent with an earlier study showing that an ER-dependent mechanism involving activation of MEK, p38 kinase, and PI3K pathways by xenoestrogens up-regulates VEGF expression in breast cancer cells . However, our current study is the first to show that BBP increases both in vitro and in vivo angiogenesis of liver cancer.
Previous reports have revealed that phthalates promote cancer cell migration, invasion and epithelial-mesenchymal transition, which may explain the cancer progression observed in both ER-dependent and AhR-dependent pathways [10, 42–44]. Several reports have shown that AhR regulates cell migration, invasion and plasticity, all of which contribute to tumor progression [10, 36, 45–47]. Our study showed that BBP promoted cell migration and invasion through the AhR/Gβ/PI3K/Akt/NF-κB pathway in hepatocellular carcinoma cells. These indicate phthalate stimulates various cell signaling pathways of cancer cell migration and invasion. Our data showed metastasis can be promoted by phthatlate in vitro and in an animal model in vivo. This is a phenomenon need to be addressed as metastasis is the key for the prognosis of cancer treatment.
Overexpression of COX-2 occurs in many pre-malignant, malignant, and metastatic cancers, including hepatocellular carcinoma. COX-2 regulates carcinogenesis by regulating angiogenesis , suppressing the immune response, and by inhibiting apoptosis, and tumor cell invasion, and metastasis . Our data suggest that BBP may contribute to angiogenesis, tumor cell invasion and metastasis by increasing COX-2 expression.
In conclusion, we revealed a nongenomic AhR mechanism that may account for the modulated progression of liver cancer after phthalate exposure. Our results imply that BBP has a promoting impact on hepatocellular carcinoma, and that phthalate should be avoided in theses patients.
Benzyl butyl phthalaye
Aryl hydrocarbon receptor
Dioxin response element.
We thank the Center for Resources, Research, and Development of Kaohsiung Medical University for support with instrumentation and the Laboratory Animal Center of Kaohsiung Medical University for assistance with animal experiments.
This work was supported by the National Science Council, Taiwan [grant number 102-2628-B-037-011-MY3 and 102-2632-B-037-001-MY3]. Kaohsiung Medical University (Hospital) Research Fund [grant numbers KMUH102-2R22, KMUH101-1R27, KMUH100-0R24]. National Sun Yat-Sen University-KMU Joint Research Project (#NSYSUKMU 102-P029).
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN. Int J Cancer. 2010, 127 (12): 2893-2917.View ArticlePubMedGoogle Scholar
- Chuang SC, La Vecchia C, Boffetta P: Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett. 2009, 286 (1): 9-14.View ArticlePubMedGoogle Scholar
- Seo KW, Kim KB, Kim YJ, Choi JY, Lee KT, Choi KS: Comparison of oxidative stress and changes of xenobiotic metabolizing enzymes induced by phthalates in rats. Food Chem Toxicol. 2004, 42 (1): 107-114.View ArticlePubMedGoogle Scholar
- Ward JM, Diwan BA, Ohshima M, Hu H, Schuller HM, Rice JM: Tumor-initiating and promoting activities of di(2-ethylhexyl) phthalate in vivo and in vitro. Environ Health Perspect. 1986, 65: 279-291.PubMedPubMed CentralGoogle Scholar
- Voss C, Zerban H, Bannasch P, Berger MR: Lifelong exposure to di-(2-ethylhexyl)-phthalate induces tumors in liver and testes of Sprague–Dawley rats. Toxicology. 2005, 206 (3): 359-371.View ArticlePubMedGoogle Scholar
- Choi S, Park SY, Kwak D, Phark S, Lee M, Lim JY, Jung WW, Sul D: Proteomic analysis of proteins secreted by HepG2 cells treated with butyl benzyl phthalate. J Toxicol Environ Health A. 2010, 73 (21–22): 1570-1585.View ArticlePubMedGoogle Scholar
- Krüger T, Long M, Bonefeld-Jørgensen EC: Plastic components affect the activation of the aryl hydrocarbon and the androgen receptor. Toxicology. 2008, 246 (2–3): 112-123.View ArticlePubMedGoogle Scholar
- Mankidy R, Wiseman S, Ma H, Giesy JP: Biological impact of phthalates. Toxicol Lett. 2013, 217 (1): 50-58.View ArticlePubMedGoogle Scholar
- Kuo CH, Hsieh CC, Kuo HF, Huang MY, Yang SN, Chen LC, Huang SK, Hung CH: Phthalates suppress type I interferon in human plasmacytoid dendritic cells via epigenetic regulation. Allergy. 2013, 68: 870-879.View ArticlePubMedGoogle Scholar
- Chen HS, Chiang PH, Wang YC, Kao MC, Shieh TH, Tsai CF, Tsai EM: Benzyl butyl phthalate induces necrosis by AhR mediation of CYP1B1 expression in human granulosa cells. Reprod Toxicol. 2011, 33 (1): 67-75.View ArticlePubMedGoogle Scholar
- Hsieh TH, Tsai CF, Hsu CY, Kuo PL, Lee JN, Chai CY, Wang SC, Tsai EM: Phthalates induce proliferation and invasiveness of estrogen receptor-negative breast cancer through the AhR/HDAC6/c-Myc signaling pathway. FASEB J. 2012, 26 (2): 778-787.View ArticlePubMedGoogle Scholar
- Guyot E, Coumoul X, Chassé JF, Khallouki F, Savouret JF, Poirot M, Barouki R: Identification of a new stilbene-derived inducer of paraoxonase 1 and ligand of the Aryl hydrocarbon Receptor. Biochem Pharmacol. 2012, 83 (5): 627-632.View ArticlePubMedGoogle Scholar
- Matsumura F: The significance of the nongenomic pathway in mediating inflammatory signaling of the dioxin-activated Ah receptor to cause toxic effects. Biochem Pharmacol. 2009, 77 (4): 608-626.View ArticlePubMedGoogle Scholar
- Sciullo EM, Dong B, Vogel CF, Matsumura F: Characterization of the pattern of the nongenomic signaling pathway through which TCDD-induces early inflammatory responses in U937 human macrophages. Chemosphere. 2009, 74 (11): 1531-1537.View ArticlePubMedPubMed CentralGoogle Scholar
- Dong B, Matsumura F: Roles of cytosolic phospholipase A2 and Src kinase in the early action of 2,3,7,8-tetrachlorodibenzo-p-dioxin through a nongenomic pathway in MCF10A cells. Mol Pharmacol. 2008, 74 (1): 255-263.View ArticlePubMedGoogle Scholar
- Li W, Matsumura F: Significance of the nongenomic, inflammatory pathway in mediating the toxic action of TCDD to induce rapid and long-term cellular responses in 3 T3-L1 adipocytes. Biochemistry. 2008, 47 (52): 13997-14008.View ArticlePubMedGoogle Scholar
- Dong B, Nishimura N, Vogel CF, Tohyama C, Matsumura F: TCDD-induced cyclooxygenase-2 expression is mediated by the nongenomic pathway in mouse MMDD1 macula densa cells and kidneys. Biochem Pharmacol. 2010, 79 (3): 487-497.View ArticlePubMedGoogle Scholar
- Nakata A, Urano D, Fujii-Kuriyama Y, Mizuno N, Tago K, Itoh H: G-protein signalling negatively regulates the stability of aryl hydrocarbon receptor. EMBO Rep. 2009, 10 (6): 622-628.View ArticlePubMedPubMed CentralGoogle Scholar
- Hsu WL1, Tsai MH, Lin MW, Chiu YC, Lu JH, Chang CH, Yu HS, Yoshioka T: Differential effects of arsenic on calcium signaling in primary keratinocytes and malignant (HSC-1) cells. Cell Calcium. 2012, 52 (2): 161-169.View ArticlePubMedGoogle Scholar
- Shu X, Royant A, Lin MZ, Aguilera TA, Lev-Ram V, Steinbach PA, Tsien RY: Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science. 2009, 324 (5928): 804-807.View ArticlePubMedPubMed CentralGoogle Scholar
- Yao X1, Hu JF, Daniels M, Yien H, Lu H, Sharan H, Zhou X, Zeng Z, Li T, Yang Y, Hoffman AR: A novel orthotopic tumor model to study growth factors and oncogenesis in hepatocarcinogenesis. Clin Cancer Res. 2003, 9 (7): 2719-2726.PubMedGoogle Scholar
- Singletary K, MacDonald C, Wallig M: The plasticizer benzyl butyl phthalate (BBP) inhibits 7, 12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary DNA adduct formation and tumorigenesis. Carcinogenesis. 1997, 18 (8): 1669-1673.View ArticlePubMedGoogle Scholar
- Liu D, Liman ER: Intracellular Ca2+ and the phospholipid PIP2 regulate the taste transduction ion channel TRPM5. Proc Natl Acad Sci U S A. 2003, 100 (25): 151601-155165.Google Scholar
- Rommel C, Camps M, Ji H: PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?. Nat Rev Immunol. 2007, 7 (3): 1912-01.View ArticleGoogle Scholar
- Yan X, Shen H, Jiang H, Hu D, Zhang C, Wang J, Wu X: External Qi of Yan Xin Q gong induces apoptosis and inhibits migration and invasion of estrogen-independent breast cancer cells through suppression of Akt/NF-kB signaling. Cell Physiol Biochem. 2010, 25 (2–3): 263-270.View ArticlePubMedGoogle Scholar
- Ge NL, Elferink CJ: A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. J Biol Chem. 1998, 273 (35): 22708-22713.View ArticlePubMedGoogle Scholar
- Zhang L, Wang JN, Tang JM, Kong X, Yang JY, Zheng F, Guo LY, Huang YZ, Zhang L, Tian L, Cao SF, Tuo CH, Guo HL, Chen SY: VEGF is essential for the growth and migration of human hepatocellular carcinoma cells. Mol Biol Rep. 2012, 39 (5): 5085-5093.View ArticlePubMedGoogle Scholar
- Hagmar L, Akesson B, Nielsen J, Andersson C, Lindén K, Attewell R, Möller T: Mortality and cancer morbidity in workers exposed to low levels of vinyl chloride monomer at a polyvinyl chloride processing plant. Am J Ind Med. 1990, 17 (5): 553-565.View ArticlePubMedGoogle Scholar
- Selenskas S, Teta MJ, Vitale JN: Pancreatic cancer among workers processing synthetic resins. Am J Ind Med. 1995, 28 (3): 385-398.View ArticlePubMedGoogle Scholar
- López-Carrillo L, Hernández-Ramírez RU, Calafat AM, Torres-Sánchez L, Galván-Portillo M, Needham LL, Ruiz-Ramos R, Cebrián ME: Exposure to phthalates and breast cancer risk in northern Mexico. Environ Health Perspect. 2010, 118 (4): 5394-44.Google Scholar
- Wang Z, Bai Z, Zhang H, Huan T, Li J, Xiumin D, Zhang J: Growth potential of human hepatocarcinoma cells in the liver of neonatal immunocompetent mice and its relation to immunological tolerance. Prog Nat Sci. 2009, 19: 705-712.View ArticleGoogle Scholar
- Apetoh L1, Quintana FJ, Pot C, Joller N, Xiao S, Kumar D, Burns EJ, Sherr DH, Weiner HL, Kuchroo VK: The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol. 2010, 11 (9): 854-861.View ArticlePubMedPubMed CentralGoogle Scholar
- Monticelli S, Sallusto F: Negative regulators take center stage. Nat Immunol. 2012, 13 (8): 7197-20.View ArticleGoogle Scholar
- Champion S, Sauzet C, Bremond P, Benbrahim K, Abraldes J, Seree E, Barra Y, Villard PH: Activation of the NF κ B Pathway Enhances AhR Expression in Intestinal Caco-2 Cells. ISRN Toxicol. 2013, doi:10.1155/2013/792452Google Scholar
- Mayati A, Levoin N, Paris H, N'diaye M, Courtois A, Uriac P, Lagadic-Gossmann D, Fardel O, Le Ferrec E: Induction of intracellular calcium concentration by environmental benzo(a)pyrene involves a β2-adrenergic receptor/adenylyl cyclase/epac-1/inositol 1,4,5-trisphosphate pathway in endothelial cells. J Biol Chem. 2012, 287 (6): 4041-4052.View ArticlePubMedGoogle Scholar
- Mulero-Navarro S, Pozo-Guisado E, Pérez-Mancera PA, Alvarez-Barrientos A, Catalina-Fernández I, Hernández-Nieto E, Sáenz-Santamaria J, Martínez N, Rojas JM, Sánchez-García I, Fernández-Salguero PM: Immortalized mouse mammary fibroblasts lacking dioxin receptor have impaired tumorigenicity in a subcutaneous mouse xenograft model. J Biol Chem. 2005, 280 (31): 28731-28741.View ArticlePubMedGoogle Scholar
- Brooks J, Eltom SE: Malignant transformation of mammary epithelial cells by ectopic overexpression of the aryl hydrocarbon receptor. Curr Cancer Drug Targets. 2011, 11 (5): 654-669.View ArticlePubMedGoogle Scholar
- Diry M, Tomkiewicz C, Koehle C, Coumoul X, Bock KW, Barouki R, Transy C: Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism. Oncogene. 2006, 25 (40): 5570-5574.View ArticlePubMedGoogle Scholar
- Kirsch M, Schackert G, Black PM: Metastasis and angiogenesis. Cancer Treat Res. 2004, 117: 285-304.View ArticlePubMedGoogle Scholar
- Roman AC, Carvajal-Gonzalez JM, Rico-Leo EM, Fernandez-Salguero PM: Dioxin receptor deficiency impairs angiogenesis by a mechanism involving VEGF-A depletion in the endothelium and transforming growth factor-beta overexpression in the stroma. J Biol Chem. 2009, 284 (37): 251352-255148.View ArticleGoogle Scholar
- Buteau-Lozano H, Velasco G, Cristofari M, Balaguer P, Perrot-Applanat M: Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism. J Endocrinol. 2008, 196 (2): 399-412.View ArticlePubMedGoogle Scholar
- Hsieh TH, Tsai CF, Hsu CY, Kuo PL, Lee JN, Chai CY, Hou MF, Chang CC, Long CY, Ko YC, Tsai EM: Phthalates stimulate the epithelial to mesenchymal transition through an HDAC6-dependent mechanism in human breast epithelial stem cells. Toxicol Sci. 2012, 128 (2): 3653-3676.View ArticleGoogle Scholar
- Zhu H, Zheng J, Xiao X, Zheng S, Dong K, Liu J, Wang Y: Environmental endocrine disruptors promote invasion and metastasis of SK-N-SH human neuroblastoma cells. Oncol Rep. 2010, 23 (1): 129-139.PubMedGoogle Scholar
- Yao PL, Lin Y, Richburg JH: Mono-(2-ethylhexyl) phthalate (MEHP) promotes invasion and migration of human testicular embryonal carcinoma cells. Biol Reprod. 2012, 86 (5): 1601-1670.View ArticleGoogle Scholar
- Peng TL, Chen J, Mao W, Song X, Chen MH: Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9. BMC Cell Biol. 2009, 16: 10-27.Google Scholar
- Bui LC, Tomkiewicz C, Chevallier A, Pierre S, Bats AS, Mota S, Raingeaud J, Pierre J, Diry M, Transy C, Garlatti M, Barouki R, Coumoul X: Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity. Oncogene. 2009, 28 (41): 3642-3651.View ArticlePubMedGoogle Scholar
- Ambolet-Camoit A, Bui LC, Pierre S, Chevallier A, Marchand A, Coumoul X, Garlatti M, Andreau K, Barouki R, Aggerbeck M: 2,3,7,8-tetrachlorodibenzo-p-dioxin counteracts the p53 response to a genotoxicant by upregulating expression of the metastasis marker agr2 in the hepatocarcinoma cell line HepG2. Toxicol Sci. 2010, 115 (2): 501-512.View ArticlePubMedGoogle Scholar
- Zhao QT, Yue SQ, Cui Z, Wang Q, Cui X, Zhai HH, Zhang LH, Dou KF: Potential involvement of the cyclooxygenase-2 pathway in hepatocellular carcinoma-associated angiogenesis. Life Sci. 2007, 80 (5): 484-492.View ArticlePubMedGoogle Scholar
- Akkız H, Bayram S, Bekar A, Akgöllü E, Ülger Y: Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma. Mol Cell Biochem. 2011, 347 (1–2): 201-208.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/14/556/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.